News | August 26, 2014

New Study First to Examine Quality of Cardiac Rehabilitation Programs in Canada

August 26, 2014 — The quality of cardiac rehabilitation programs across Canada is strong, with specific criteria areas now identified as requiring further enhancement to improve patient outcomes, according to a new study conducted by researchers at the Peter Munk Cardiac Center, York University and the University Health Network (UHN).

“We are the first to comprehensively assess cardiac rehabilitation quality—what we are doing well and where we should do better—to this degree across the country,” said Sherry Grace, M.D., study author and director of research, GoodLife Fitness Cardiovascular Rehabilitation Unit, University Health Network, and York University kinesiology and health science professor. “Being able to rigorously evaluate and compare across cardiac rehabilitation programs nationally means gaps can be addressed and changes made, to ultimately benefit patients who have heart disease.”

Set to be published in the Canadian Journal of Cardiology, the study measured 14 key quality indicators in 10 cardiac rehabilitation programs across Canada, assessing more than 5,500 cardiac patients. The criteria examined included: accessibility, wait times, referrals, secondary prevention, behavior changes and psychosocial measures.

“Recovery from a heart attack, open-heart surgery or other related procedures improves substantially when a patient participates fully in a cardiac rehabilitation program,” said Barry Rubin, M.D., Ph.D., FRCSC, medical director, Peter Munk Cardiac Center. “With tens of thousands of new patients across Canada being treated for heart disease each year, it is imperative that patients participate in the program of exercise and education that form the basis for cardiac rehab as part of their recovery, to prevent their risk of experiencing another serious cardiac event. This leading-edge study makes that goal more attainable.”

The study found that cardiac rehabilitation programs are successful in: assessing patients’ body composition (85 percent), measuring blood pressure (90 percent), increasing exercise capacity (68 percent) and offering cessation therapy to patients who smoke (61 percent). Areas requiring improvement included: measuring blood sugar in patients with diabetes (23 percent) and assessment of depression (13 percent).

Research has shown that heart patients who engage in cardiac rehab are 25 percent less likely to die, than patients who do not participate in cardiac rehab. At the same time, only about 30 percent of heart patients who are hospitalized and who qualify to participate in a cardiac rehab program actually do so.

The United States and Europe have also developed some quality indicators for cardiac rehab. Canada is the first country to nationally assess program quality.

The study was funded in part by the BRIDGE project managed by the Canadian Cardiovascular Society and funded by the Public Health Agency of Canada.

For more information:

Related Content

Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Cardiovascular Clinical Studies | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Cardiovascular Clinical Studies | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Cardiovascular Clinical Studies | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Cardiovascular Clinical Studies | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Cardiovascular Clinical Studies | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Cardiovascular Clinical Studies | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Cardiovascular Clinical Studies | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init